Northwestern Mutual Wealth Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31.2K | Buy |
553
+107
| +24% | +$6.97K | ﹤0.01% | 2627 |
|
|
2025
Q4 | $35.7K | Sell |
446
-102
| -19% | -$6.85K | ﹤0.01% | 2526 |
|
|
2025
Q3 | $26.7K | Buy |
548
+25
| +5% | +$1.55K | ﹤0.01% | 2563 |
|
|
2025
Q2 | $39K | Buy |
523
+3
| +0.6% | +$199 | ﹤0.01% | 2352 |
|
|
2025
Q1 | $33K | Sell |
520
-184
| -26% | -$12.5K | ﹤0.01% | 2318 |
|
|
2024
Q4 | $55K | Hold |
704
| – | – | ﹤0.01% | 2152 |
|
|
2024
Q3 | $56.6K | Hold |
704
| – | – | ﹤0.01% | 2111 |
|
|
2024
Q2 | $58.2K | Sell |
704
-161
| -19% | -$14.2K | ﹤0.01% | 2037 |
|
|
2024
Q1 | $73.8K | Buy |
865
+363
| +72% | +$28.5K | ﹤0.01% | 1929 |
|
|
2023
Q4 | $42.9K | Buy |
+502
| New | +$43.4K | ﹤0.01% | 2108 |
|
|
2023
Q2 | – | Sell |
-5
| Closed | -$414 | – | 3450 |
|
|
2023
Q1 | $414 | Buy |
+5
| New | +$405 | ﹤0.01% | 3124 |
|
|
2022
Q2 | – | Sell |
-3
| Closed | – | – | 3292 |
|
|
2022
Q1 | $0 | Buy |
3
+2
| +200% | +$109 | ﹤0.01% | 3226 |
|
|
2021
Q4 | $0 | Buy |
+1
| New | +$61 | ﹤0.01% | 3218 |
|
|
2021
Q1 | – | Sell |
-15
| Closed | -$2K | – | 2859 |
|
|
2020
Q4 | $2K | Buy |
15
+11
| +275% | +$1.18K | ﹤0.01% | 2530 |
|
|
2020
Q3 | $0 | Sell |
4
-744
| -99% | -$65K | ﹤0.01% | 2594 |
|
|
2020
Q2 | $67K | Buy |
748
+277
| +59% | +$28K | ﹤0.01% | 1355 |
|
|
2020
Q1 | $47K | Hold |
471
| – | – | ﹤0.01% | 1409 |
|
|
2019
Q4 | $54K | Buy |
+471
| New | +$57K | ﹤0.01% | 1439 |
|
|
2017
Q3 | – | Sell |
-35
| Closed | -$1K | – | 2194 |
|
|
2017
Q2 | $1K | Buy |
+35
| New | +$1.44K | ﹤0.01% | 1942 |
|
|
2016
Q2 | – | Sell |
-139
| Closed | -$5K | – | 2136 |
|
|
2016
Q1 | $5K | Buy |
+139
| New | +$4.49K | ﹤0.01% | 1637 |
|
|
2015
Q4 | – | Sell |
-200
| Closed | -$6K | – | 1698 |
|
|
2015
Q3 | $6K | Buy |
200
+170
| +567% | +$6.4K | ﹤0.01% | 1203 |
|
|
2015
Q2 | $1K | Hold |
30
| – | – | ﹤0.01% | 1315 |
|
|
2015
Q1 | $1K | Hold |
30
| – | – | ﹤0.01% | 1456 |
|
|
2014
Q4 | $1K | Hold |
30
| – | – | ﹤0.01% | 1616 |
|
|
2014
Q3 | $1K | Hold |
30
| – | – | ﹤0.01% | 1258 |
|
|
2014
Q2 | $1K | Hold |
30
| – | – | ﹤0.01% | 1195 |
|
|
2014
Q1 | $1K | Hold |
30
| – | – | ﹤0.01% | 1202 |
|
|
2013
Q4 | $1K | Hold |
30
| – | – | ﹤0.01% | 1304 |
|
|
2013
Q3 | $1K | Hold |
30
| – | – | ﹤0.01% | 1270 |
|
|
2013
Q2 | $1K | Buy |
+30
| New | +$1.22K | ﹤0.01% | 1180 |
|
Other funds holding HAE
VPM
VCM
RRAM
Northwestern Mutual Wealth Management's HAE Position: Q1 2026 in Review
Northwestern Mutual Wealth Management increased its Haemonetics (HAE) stake by 24% in Q1 2026, buying an estimated $6.97K and bringing the position to 553 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2627.
Northwestern Mutual Wealth Management first reported a position in HAE in Q2 2013 and has held it in 30 quarters since. The position peaked at $73.8K in Q1 2024. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- Northwestern Mutual Wealth Management held 553 shares of Haemonetics worth $31.2K as of Q1 2026.
- Northwestern Mutual Wealth Management bought 107 Haemonetics shares in Q1 2026, an estimated $6.97K.
- Haemonetics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #2627 holding.
- Northwestern Mutual Wealth Management first reported a position in Haemonetics in Q2 2013 and has held it in 30 quarters since.
- Northwestern Mutual Wealth Management's Haemonetics position peaked at $73.8K in Q1 2024.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.